Keyword search (4,163 papers available)

"amyloid beta" Keyword-tagged Publications:

Title Authors PubMed ID
1 Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer s disease Sanami S; Intzandt B; Huck J; Villeneuve S; Iturria-Medina Y; Gauthier CJ; Prevent-Ad Research Group None; 40347524
CONCORDIA
2 Sleep spindles and slow oscillations predict cognition and biomarkers of neurodegeneration in mild to moderate Alzheimer's disease Páez A; Gillman SO; Dogaheh SB; Carnes A; Dakterzada F; Barbé F; Dang-Vu TT; Ripoll GP; 39878233
CONCORDIA
3 Amyloid-β (1-42) peptide induces rapid NMDA receptor-dependent alterations at glutamatergic synapses in the entorhinal cortex Olajide OJ; Chapman CA; 34144329
PSYCHOLOGY
4 Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease. Olajide OJ, Suvanto ME, Chapman CA 33495355
PSYCHOLOGY
5 Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment Pascoal TA, Therriault J, Mathotaarachchi S, Kang MS, Shin M, Benedet AL, Chamoun M, Tissot C, Lussier F, Mohaddes S, Soucy JP, Massarweh G, Gauthier S, Rosa-Neto P, 32582834
PERFORM

 

Title:Topographical distribution of Aβ predicts progression to dementia in Aβ positive mild cognitive impairment
Authors:Pascoal TA,  Therriault J,  Mathotaarachchi S,  Kang MS,  Shin M,  Benedet AL,  Chamoun M,  Tissot C,  Lussier F,  Mohaddes S,  Soucy JP,  Massarweh G,  Gauthier S,  Rosa-Neto P
Link:https://pubmed.ncbi.nlm.nih.gov/32582834/?utm_source=MS-Office&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1deGMjvjVspk9gsE
DOI:10.1002/dad2.12037
Publication:Alzheimer' s & dementia (Amsterdam, Netherlands)
Keywords:Alzheimer';  s disease;  amyloid beta;  mild cognitive impairment;  positron emission tomography; 
PMID:32582834 Category: Date Added:2020-06-25
Dept Affiliation: PERFORM
1 Translational Neuroimaging Laboratory Alzheimer's Disease Research Unit The McGill University Research Centre for Studies in Aging McGill University Montreal Quebec Canada.
2 Department of Neurology and Neurosurgery McGill University Montreal Quebec Canada.
3 Montreal Neurological Institute Montreal Quebec Canada.
4 PERFORM Centre Concordia University Montreal Quebec Canada.

Description:

INTRODUCTION: Abnormal brain amyloid beta (Aß) is typically assessed in vivo using global concentrations from cerebrospinal fluid and positron emission tomography (PET). However, it is unknown whether the assessment of the topographical distribution of Aß pathology can provide additional information to identify, among global Aß positive individuals, those destined for dementia.




BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University